The trade-off between population and individual benefit of screening

Zeitschrift fur Arztliche Fortbildung und Qualitatssicherung

Volumn 100, Issue 7, 2006, Pages 505-513

  Hense, Hans W ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Cancer registry; Evaluation of screening programmes; Interval cancer; Public health

Indexed keywords

BREAST CANCER; CANCER DIAGNOSIS; CANCER REGISTRY; CANCER SCREENING; CAUSE OF DEATH; DIAGNOSTIC ACCURACY; ECHOMAMMOGRAPHY; EDUCATION PROGRAM; GERMANY; HEALTH CARE SYSTEM; HUMAN; MEDICAL EXAMINATION; MELANOMA; MONEY; POLITICS; PROSTATE CANCER; PUBLIC HEALTH SERVICE; REVIEW; TUMOR BIOPSY;

BREAST NEOPLASMS; GERMANY; HUMANS; MAMMOGRAPHY; MASS SCREENING; NEOPLASM INVASIVENESS; NEOPLASMS; REPRODUCIBILITY OF RESULTS;

EID: 33751033592     PISSN: 14317621     EISSN: 16180992     Source Type: Journal    
DOI: None     Document Type: Review

References (4)

1. Lynge E, Olsen AH, Fracheboud J, Patnick J. Reporting of performance indicators of mammography screening in Europe. Eur J Cancer Prev 2003;12:213-22.
2. Otto SJ, Fracheboud J, Looman CW, Broeders MJ, Boer R, Hendriks JH et al. National Evaluation Team for Breast Cancer Screening. Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review. Lancet 2003;361:1411-7.
3. Bonneux L. Mortality reduction by breast-cancer screening. Lancet 2003;362:245.
4. Welch G, Woloshin S, Schwartz LM. Skin biopsy rates and incidence of melanoma: population based ecological study. BMJ 2005;331:481.